User profiles for O. Kallioniemi

Olli Kallioniemi

Director, Science for Life Laboratory and the data-driven life science program
Verified email at scilifelab.se
Cited by 77880

Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

OP Kallioniemi, A Kallioniemi, J Piper… - Genes …, 1994 - Wiley Online Library
O) representing the mean green to red ratio for the entire metaphase is shown in a dashed
line and ratios 0.5 and 1.5 as dotted lines. Based on this analysis, the chromosomal regions …

Tissue microarray technology for high-throughput molecular profiling of cancer

OP Kallioniemi, U Wagner, J Kononen… - Human molecular …, 2001 - academic.oup.com
Tissue microarray (TMA) technology allows rapid visualization of molecular targets in
thousands of tissue specimens at a time, either at the DNA, RNA or protein level. The technique …

MicroRNA in prostate, bladder, and kidney cancer: a systematic review

…, CP Evans, S Fussel, FC Hamdy, O Kallioniemi… - European urology, 2011 - Elsevier
CONTEXT: MicroRNAs (miRNA) are noncoding RNAs that post-transcriptionally regulate
gene expression. Their altered expression and function have been observed in most urologic …

[PDF][PDF] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined …

…, H Nevanlinna, K Syrjäkoski, OP Kallioniemi… - The American Journal of …, 2003 - cell.com
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer,
but the average magnitude of these risks is uncertain and may depend on the context. …

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

A Kallioniemi, OP Kallioniemi, D Sudar, D Rutovitz… - Science, 1992 - science.org
… AK and O.-PK have received support from the Finnish Science Academy, Finnish and
Pirkanmaa Cancer Societies, Lahtikari Foundation, and Pirkanmaa Cultural Foundation (Finland). …

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

…, MM Tanner, XY Guan, G Sauter, OP Kallioniemi… - Science, 1997 - science.org
Members of the recently recognized SRC-1 family of transcriptional coactivators interact with
steroid hormone receptors to enhance ligand-dependent transcription. AIB1, a member of …

[HTML][HTML] Gene-expression profiles in hereditary breast cancer

…, B Wilfond, G Sauter, OP Kallioniemi… - … England Journal of …, 2001 - Mass Medical Soc
Background Many cases of hereditary breast cancer are due to mutations in either the
BRCA1 or the BRCA2 gene. The histopathological changes in these cancers are often …

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

…, A Palotie, T Tammela, J Isola, OP Kallioniemi - Nature …, 1995 - nature.com
Overexpression of amplified genes is often associated with the acquisition of resistance to
cancer therapeutic agents in vitro. We have identified a similar molecular mechanism in vivo …

High frequency of BRAF mutations in nevi

…, T Pohida, P Heenan, P Duray, O Kallioniemi… - Nature …, 2003 - nature.com
To evaluate the timing of mutations in BRAF (v-raf murine sarcoma viral oncogene homolog
B1) during melanocytic neoplasia, we carried out mutation analysis on microdissected …

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

A Kallioniemi, OP Kallioniemi, J Piper… - Proceedings of the …, 1994 - National Acad Sciences
… lq (36% of primary tumors/40% of cell lines) and at 8q (27%/40%), whereas regional copy-number
increases were seen repeatedly at 17q22-q24 (18%/67%) and at 20q13 (18%/40%o). …